Proc Natl Acad Sci 97(10):51015106
Smakowski A, Adamson J, Turner T, Chalder T
Evidence suggests these dual pathways create enhanced effects on both homeostatic and hedonic appetite systems in the hypothalamus, hindbrain, and septum, producing greater metabolic benefits than either agent individually
and reduced fasting blood glucose and oxidative stress markers
While early animal studies and lab research suggest promising effects on tissue healing and inflammation, high-quality human clinical trials are lacking
GLP-1 medications work by mimicking natural GLP-1 hormones, enhancing their effect on key organs: Brain : GLP-1 receptors in the hypothalamus (hunger center) reduce food intake and cravings